Sis-25, a meroditerpenoid derivative with a cyclobutane scaffold, inhibits activated T cell proliferation by targeting GSK3β in vitro and in vivo
-
Published:2022-08
Issue:
Volume:929
Page:175151
-
ISSN:0014-2999
-
Container-title:European Journal of Pharmacology
-
language:en
-
Short-container-title:European Journal of Pharmacology
Author:
Liu YangORCID,
Li Xingren,
Wu Xiuyin,
Luo Xingyan,
Yan Bingchao,
Mo Chunfen,
Guo Huijie,
Yang Shuxia,
Wang Yantang,
Lai Yi,
Puno Pematenzin,
Li Limei
Reference37 articles.
1. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes;Ajchenbaum;J. Biol. Chem.,1993
2. Novel therapies for immune-mediated inflammatory diseases: what can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?;Baker;Ann. Rheum. Dis.,2018
3. mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3 beta;Bautista;J. Biol. Chem.,2018
4. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases;Beurel;Pharmacol. Ther.,2015
5. Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3;Beurel;J. Immunol.,2013
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献